We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gene for Cardiac Septal Defects Identified

By Biotechdaily staff writers
Posted on 21 Jul 2003
Researchers have found that a mutation in the gene GATA4 causes congenital cardiac septal defects, which occur when the walls separating the heart's four chambers do not form properly.

Investigators at the University of Texas Southwestern Medical Center (Dallas, USA) performed genetic linkage analyses on members of two families, one in the United States that spanned five generations and included 16 members suffering from congenital heart defects, and the other from Japan that spanned four generations and included eight members with defects. More...
Analyses were also performed on more than 3,000 unrelated individuals.

The results, published July 6, 2003, in the online edition of Nature, showed that cardiac septal defects were linked to chromosome 8p22-23. A heterozygous G296S missense mutation of GATA4, a transcription factor essential for heart formation, was found in all available affected family members but not in any unaffected family members or in control individuals. This mutation resulted in diminished DNA-binding affinity and transcriptional activity of GATA4. Furthermore, the GATA4 mutation abrogated a physical interaction between GATA4 and TBX5, a T-box protein responsible for a subset of syndromic cardiac septal defects.

"This discovery could one day help doctors prevent congenital heart defects, the most common developmental anomaly, by fixing the problem before a baby is born,” said senior author Dr. Deepak Srivastava, associate professor of pediatrics and molecular biology at University of Texas Southwestern Medical Center. "We cannot change the fact that parents are going to pass along the mutation, but we might be able to develop a way to keep the disease from occurring.”

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.